Statements of Stockholder's Equity (Deficit) - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning balance at Dec. 31, 2020	$ 17	$ 765,162	$ (134,441)	$ 630,738
Beginning balance (in shares) at Dec. 31, 2020	168,008
Issuance of common stock, value		3,822		3,822
Issuance of common stock (in shares)	2,136
Common stock issued for exercise of warrants	$ 1	194,797		194,798
Common stock issued for exercise of warrants (in shares)	7,984
Common stock issued under Equity Purchase Agreement		20,000		20,000
Common stock issued under Equity Purchase Agreement (in shares)	3,947
Stock compensation		12,365		12,365
Net loss			(329,217)	(329,217)
Ending balance at Sep. 30, 2021	$ 18	996,146	(463,658)	532,506
Ending balance (in shares) at Sep. 30, 2021	182,075
Beginning balance at Jun. 30, 2021	$ 18	966,837	(367,852)	599,003
Beginning balance (in shares) at Jun. 30, 2021	176,606
Issuance of common stock, value		2,724		2,724
Issuance of common stock (in shares)	1,522
Common stock issued under Equity Purchase Agreement		20,000		20,000
Common stock issued under Equity Purchase Agreement (in shares)	3,947
Stock compensation		6,585		6,585
Net loss			(95,806)	(95,806)
Ending balance at Sep. 30, 2021	$ 18	996,146	(463,658)	532,506
Ending balance (in shares) at Sep. 30, 2021	182,075
Beginning balance at Dec. 31, 2021	$ 19	1,084,390	(544,809)	539,600
Beginning balance (in shares) at Dec. 31, 2021	196,391
Issuance of common stock, value	$ 1	1,852		1,853
Issuance of common stock (in shares)	1,106
RSU Vesting (in shares)	1,944
Common stock issued under Equity Purchase Agreement	$ 2	40,437		40,439
Common stock issued under Equity Purchase Agreement (in shares)	17,464
Stock compensation		10,949		10,949
Net loss			(180,404)	(180,404)
Ending balance at Sep. 30, 2022	$ 22	1,137,628	(725,213)	412,437
Ending balance (in shares) at Sep. 30, 2022	216,905
Beginning balance at Jun. 30, 2022	$ 21	1,106,521	(570,783)	535,759
Beginning balance (in shares) at Jun. 30, 2022	205,871
RSU Vesting (in shares)	132
Common stock issued under Equity Purchase Agreement	$ 1	26,704		26,705
Common stock issued under Equity Purchase Agreement (in shares)	10,902
Stock compensation		4,403		4,403
Net loss			(154,430)	(154,430)
Ending balance at Sep. 30, 2022	$ 22	$ 1,137,628	$ (725,213)	$ 412,437
Ending balance (in shares) at Sep. 30, 2022	216,905